Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Haemonetics (NYSE: HAE) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Chris Simon, President and CEO, is scheduled to present on Tuesday, January 14, 2025, at 5:15 pm Pacific Time.

The presentation will be accessible to the public through a live audio webcast via the conference platform and through Haemonetics' Investor Relations website under the Events & Presentations section. A replay of the presentation will remain available for 30 days following the event, accessible through both platforms approximately one hour after the live presentation concludes.

News Market Reaction

-1.55%

1 alert

-1.55% News Effect

On the day this news was published, HAE declined 1.55%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time.

The public may access Mr. Simon's presentation live via audio webcast at:

https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true 

The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics (HAE) presenting at the 2025 J.P. Morgan Healthcare Conference?

Haemonetics (HAE) is presenting on Tuesday, January 14, 2025, at 5:15 pm Pacific Time.

How can investors access Haemonetics' (HAE) J.P. Morgan Healthcare Conference presentation?

Investors can access the presentation through a live audio webcast via the conference platform or through Haemonetics' Investor Relations website under Events & Presentations section.

How long will the replay of HAE's J.P. Morgan Healthcare Conference presentation be available?

The replay will be available for 30 days after the event, accessible approximately one hour after the live presentation ends.

Who is presenting for Haemonetics (HAE) at the 2025 J.P. Morgan Healthcare Conference?

Chris Simon, President and CEO of Haemonetics, will be presenting at the conference.